← Back to Search

Behavioral Intervention

Lifestyle Coaching for Lupus-Related Fatigue (LIFT Trial)

N/A
Recruiting
Led By Rosalind Ramsey-Goldman, MD, DrPH
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Meeting at least 4 of 11 American College of Rheumatology (ACR) classification criteria for definite SLE, or 3 out of 11 ACR classification criteria with also meeting at least one SLICC criteria
Being at least 18 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3, 6, 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at whether coaching sessions focused on physical activity and nutrition can help decrease fatigue for people with lupus.

Who is the study for?
This trial is for adults over 18 with systemic lupus erythematosus (SLE) who meet specific diagnostic criteria. Participants should have a Body Mass Index (BMI) of 18-40, be able to walk short distances and understand English. Pregnant individuals or those not meeting these conditions cannot join.
What is being tested?
The study compares two groups: one receives coaching on physical activity and nutrition, while the other gets calls about SLE self-management education. The goal is to see if the intervention can reduce fatigue and improve exercise habits and diet in SLE patients over a year.
What are the potential side effects?
Since this trial focuses on lifestyle interventions like exercise and nutrition coaching rather than medication, side effects are minimal but may include muscle soreness or dietary changes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I meet the criteria for a definite lupus diagnosis.
Select...
I am 18 years old or older.
Select...
I can walk at least the length of a house without help.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3, 6, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3, 6, 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Fatigue Severity Scale over time
Secondary study objectives
Change in International Physical Activity Questionnaire (IPAQ) over time
Change in Physical Activity Scale over time
Godin Leisure Time Exercise Questionnaire
Other study objectives
Change in Nutrition Data Systems for Research (NDSR) over time

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
The experimental intervention is a unique combination of four individual counseling sessions based in motivational interviewing focusing on physical activity, dietary behavior and behavioral strategies. The individual sessions will provide a tailored personalized intervention including problem-solving and goal setting for increasing physical activity, and following a healthy diet. Healthy Lifestyle Coaches (RN or MPH) will be responsible for conducting the individual for a caseload of participants. There are no drugs involved in the intervention.
Group II: ControlActive Control1 Intervention
The control group intervention will receive four individual phone calls checking in with participants regarding questions about the study or from the educational sessions focusing on SLE disease management, each lasting approximately 10-15 minutes.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Experimental
2008
Completed Phase 2
~2200

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,644 Previous Clinical Trials
958,268 Total Patients Enrolled
Rosalind Ramsey-Goldman, MD, DrPHPrincipal Investigator - Northwestern University
Northwestern Memorial Hospital
Case Western Reserve University School Of Medicine (Medical School)
Rochester Gen Hospital (Residency)
2 Previous Clinical Trials
72 Total Patients Enrolled

Media Library

Experimental (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT02653287 — N/A
Fatigue and Malaise Research Study Groups: Intervention, Control
Fatigue and Malaise Clinical Trial 2023: Experimental Highlights & Side Effects. Trial Name: NCT02653287 — N/A
Experimental (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02653287 — N/A
Fatigue and Malaise Patient Testimony for trial: Trial Name: NCT02653287 — N/A
~0 spots leftby Dec 2024